Sebastian M Christ, Kaspar Pohl, Jonas Willmann, Philip Heesen, Astrid Heusel, Maiwand Ahmadsei, Anja Kühnis, Eugenia Vlaskou Badra, Urs J Muehlematter, Michael Mayinger, Panagiotis Balermpas, Nicolaus Andratschke, Nicholas Zaorsky, Martin Huellner, Matthias Guckenberger
INTRODUCTION AND BACKGROUND: Metastatic disease has been proposed as a continuum, with no clear cut-off between oligometastatic and polymetastatic disease. This study aims to quantify tumor burden and patterns of spread in unselected metastatic cancer patients referred for PET-based staging, response assessment of restaging. MATERIALS AND METHODS: All oncological fluorodeoxyglucose (FDG-) and prostate-specific membrane antigen (PSMA-) positron emission tomography (PET) scans conducted at a single academic center in 2020 were analyzed...
March 2024: Clinical and Translational Radiation Oncology